FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to pharmaceutics and medicine. 1 object is a preparation for stimulating regeneration and neuroprotection of nerve tissue, containing a recombinant adeno-associated virus of serotype 9, containing a codon-optimized gene sequence selected from: GDNF represented by SEQ ID NO: 1; CNTF represented by SEQ ID NO: 2; VEGF represented by SEQ ID NO: 3; or any combination thereof. 2 object is a method for stimulating regeneration and neuroprotection of nerve tissue, which consists in single or multiple intraspinal, or intrathecal, or intravenous introduction of the preparation.
EFFECT: stimulation of regeneration and neuroprotection of nerve tissue.
2 cl, 4 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY AND A METHOD FOR ITS TREATMENT | 2021 |
|
RU2769577C1 |
| COMPOSITION FOR NEUROPROTECTION AND STIMULATION OF BRAIN NEUROREGENERATION AFTER INJURY, AGENT BASED ON IT, A METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2803286C1 |
| METHOD FOR PREVENTIVE GENE THERAPY FOR SUPPRESSING NEURON DEATH IN ISCHEMIC BRAIN STROKE | 2020 |
|
RU2748940C2 |
| METHOD FOR SIMULATING ANGIOGENESIS, TREATING NEUROGENERATIVE DISEASES AND REGENERATING SKELETAL MUSCLE USING PLASMID CONSTRUCTS WITH GENES FOR ANGIOGENIC AND NEUROTROPHIC FACTORS | 2020 |
|
RU2805082C2 |
| GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
| METHOD FOR THERAPY FOR TAY-SACHS DISEASE AND SANDHOFF DISEASE USING GENETICALLY MODIFIED HUMAN MESENCHYMAL STEM CELLS WITH OVEREXPRESSION OF β-HEXOSAMINIDASE A | 2020 |
|
RU2748383C1 |
| AGENT FOR REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN AND METHOD OF CELL-MEDIATED GENE THERAPY FOR ISCHEMIC STROKE OF BRAIN BY REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN | 2017 |
|
RU2676701C1 |
| ADENO-ASSOCIATED VIRUS VECTOR | 2015 |
|
RU2743382C2 |
| RECOMBINANT GENETIC CONSTRUCT, ADENO-ASSOCIATED VIRUS FOR THERAPY OF METACHROMATIC LEUKODYSTROPHY | 2023 |
|
RU2821568C1 |
| METHOD OF PERSONALIZED GENE THERAPY IN CASE THERE IS THREAT OF ISCHEMIC CEREBRAL STROKE | 2023 |
|
RU2808256C1 |
